Chemoinformaics analysis of (1S,3R,5S)-6,6-DIMETHYL-2-METHYLIDENEBICYCLO[3.1.1]HEPTAN-3-OL
| Molecular Weight | 152.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 24 |
| Exact Molecular Weight | 152.12 | nRing | 3 |
| Solubility: LogS | -3.932 | nHRing | 0 |
| Solubility: LogP | 0.245 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.238 |
| Synth | 3.958 |
| Natural Product Likeliness | 1.967 |
| NR-PPAR-gamma | 0.941 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.883 |
| HIA | 0.789 |
| CACO-2 | -6.131 |
| MDCK | 0.0000178 |
| BBB | 0.073 |
| PPB | 0.841187 |
| VDSS | 0.936 |
| FU | 0.146274 |
| CYP1A2-inh | 0.061 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.361 |
| CYP2d6-inh | 0.06 |
| CYP2d6-sub | 0.212 |
| CYP3a4-inh | 0.051 |
| CYP3a4-sub | 0.02 |
| CL | 5.965 |
| T12 | 0.793 |
| hERG | 0.012 |
| Ames | 0.817 |
| ROA | 0.065 |
| SkinSen | 0.083 |
| Carcinogencity | 0.042 |
| EI | 0.027 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.881 |
| Antiviral | No |
| Prediction | 0.937852 |